TITLE
Activating Clinicians to Deliver Effective Obesity Care

PROGRAM DESCRIPTION
While enormous strides have been made in recent years relative to the development of safe and effective anti-obesity medications, these agents remain underused in clinical practice. There is a clear need to educate primary care clinicians about how to identify and actively treat individuals who are overweight and obese to mitigate weight-related health risks and improve overall quality of life.  
In this activity, participants will be guided through a series of small group learning modules by a group leader who is a well-recognized American Board of Obesity Medicine-certified clinician in their community. The curriculum focuses on the group’s collective accomplishment of a shared goal—improving outcomes for patients with obesity via the application of the most recent evidence-based guidelines for treatment, including the use of pharmacologic therapies for the reduction of weight-related health risks. 

EDUCATIONAL OBJECTIVES
After taking part in this educational activity, clinicians should be better able to:

• Apply the most recent evidence-based guidelines for the identification of obesity in adults and other populations
• Describe the underlying pathophysiology of obesity and metabolic adaptations that prevent significant, long-term weight loss and implications for obesity treatment
• Utilize current and emerging evidence-based pharmacologic treatment options for obesity, taking into account the latest clinical trial data and updated practice guidelines
• Implement education and principles of shared decision-making for improved outcomes among individuals with obesity

INTENDED AUDIENCES
This activity is intended for US-based Primary Care Physicians, Nurse Practitioners, and Physician Assistants

COMMERCIAL SUPPORTER
This activity is supported by an educational grant from Lilly.

ACCREDITED PROVIDER & ACCREDITATION STATEMENTS
Accredited by Haymarket Medical Education.
 

In support of improving patient care, Haymarket Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

CREDIT DESIGNATION STATEMENTS

03.00 IPCE credits
This activity was planned by and for the healthcare team, and learners will receive 3.0 Interprofessional Continuing Education (IPCE) credits for learning and change.

03.00 AMA PRA Category 1 Credits™
Haymarket Medical Education designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

03.00 ANCC Contact Hours
This activity is awarded 3.0 contact hours (based on 60 minutes per contact hour).

03.00 AAPA Category 1 CME credit (enduring)
Haymarket Medical Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 3.0 AAPA Category 1 CME credits. Approval is valid until 3/31/2024. PAs should only claim credit commensurate with the extent of their participation.

DISCLOSURE OF FINANCIAL RELATIONSHIPS POLICY
Haymarket Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME/CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

DISCLOSURE OF UNLABELED USE 
This IPCE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this IPCE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a clinician relative to diagnostic and treatment options for a specific patient’s medical condition.

DISCLAIMER
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Haymarket Medical Education and Lilly. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

If you have any questions relating to the accreditation of this activity, please contact cme.questions@haymarketmedical.com.

FACULTY

Robert F. Kushner, MD, MS, FACP, DABOM
Professor, Departments of Medicine and Medical Education
Northwestern University Feinberg School of Medicine
Director, Center for Lifestyle Medicine, Northwestern Medicine
Chicago, IL

Dr. Kushner has disclosed the following financial relationships:
Advisory Boards: Novo Nordisk, Inc., WW
Clinical Research: Epitomee Medical
Consultant: Altimmune, Eli Lilly and Company, Pfizer Inc. 

Ken Fujioka, MD
Director, Nutrition and Metabolic Research
Scripps Clinic, Dept of Diabetes and Endocrine
San Diego, CA

Dr. Fujioka has disclosed the following financial relationships:
Consultant: Novo Nordisk, Inc., Gelesis, Currax, Amgen, Phenomix, Boehringer Ingelheim, Rhythm, Takeda, Vectiv Bio, Shionogi, Eli Lilly and Company
Speakers Bureau: Novo Nordisk, Inc., Rhythm, Takeda

All of the relevant financial relationships listed for these individuals have been mitigated.

ACCREDITED PROVIDER DISCLOSURE 
None of the planners, reviewers, and Haymarket Medical Education staff for this educational activity have relevant financial relationship(s) with ineligible companies to disclose.  

METHOD OF PARTICIPATION/INSTRUCTIONS
To obtain credit, a score of 70% or better on the Final Assessment is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the Final Assessment, Post Group Assessment and evaluation, and have received a digital copy of your credit certificate. 

In order to claim the maximum amount of credit available, you must complete all of the following:

• Baseline Assessment - 0.25 credit hours
• Self-Study Module 1 - 0.25 credit hours
• Self-Study Module 2 - 0.50 credit hours
• Group Challenge 1 - 0.25 credit hours 
• Group Challenge 2 - 0.50 credit hours
• Live Group Discussion 1 - 0.50 credit hours
• Live Group Discussion 2 - 0.50 credit hours
• Final Assessment – 0.25 credit hours